$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Activated matrix and method of activation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C08L-001/00
출원번호 US-0128847 (1980-03-10)
발명자 / 주소
  • Ayers John S. (Palmerston North NZX) Bethell Geoffrey S. (Palmerston North NZX) Hancock William S. (Palmerston North NZX) Hearn Milton T. W. (Dunedin North NZX)
출원인 / 주소
  • Development Finance Corporation of New Zealand (Wellington NZX 03)
인용정보 피인용 횟수 : 204  인용 특허 : 2

초록

The invention relates to the carbonylation of cross linked substituted and unsubstituted polysaccharides, their copolymers with macroporous synthetic polymers, macroporous synthetic polymers and rigid supports with pendant hydroxyalkyl groups. The carbonylated product can be used to prepare an affin

대표청구항

A compound of the general formula III [Figure] III wherein MATRIX is a water and organic insoluble radical selected from the group consisting of: cross-linked polysaccharides, subsituted by C2-C8 alkyl or alkenyl groups, macroporous synthetic polymers, co-polymers of cross-linked substituted polysac

이 특허에 인용된 특허 (2)

  1. Ayers John S. (Palmerston North) Bethell Geoffrey S. (Palmerston North) Hancock William S. (Palmerston North) Hearn Milton T. W. (Dunedin North), Activated matrix and method of activation.
  2. Ferruti Paolo (V.le Cassiodoro ; 24 Milan ITX) Paoletti Rodolfo (V.le Regina Margherita ; 43 Milan ITX), Novel prostaglandin precursors in polymeric form.

이 특허를 인용한 특허 (204)

  1. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, 5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta.
  2. Kesicki, Edward A.; Fowler, Kerry W.; Huang, Danwen; Ooi, Hua Chee; Oliver, Amy; Puri, Kamal Deep; Ruan, Fuqiang; Treiberg, Jennifer, 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta.
  3. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta.
  4. Kesicki, Edward A.; Fowler, Kerry W.; Huang, Danwen; Ooi, Hua Chee; Oliver, Amy; Puri, Kamal Deep; Ruan, Fuqiang; Treiberg, Jennifer, 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta.
  5. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta.
  6. Moriguchi Soyao (Tokyo JPX) Nakayama Yoshito (Tokyo JPX) Suzuki Hiroshi (Tokyo JPX) Ishii Tae (Tokyo JPX) Shioda Seiji (Tokyo JPX) Kaiho Isao (Tokyo JPX), Active support substance and adsorbent for chromatography.
  7. Shibata Tohru (Himeji JPX) Okamoto Ichiro (Himeji JPX), Agent for separation.
  8. Chambers, Ross S.; Brown, Michael C.; Onisk, Dale V.; Stafford, L. Joe; Yin, Fenglin, Anti-human CXCR4 antibodies and methods of making same.
  9. Adams, Camellia W; Ashkenazi, Avi J; Chuntharapai, Anan; Kim, Kyung Jin, Antibodies to Apo-2 receptor polypeptides.
  10. Xiao, Shouhua; Pan, Zheng; Wickramasinghe, Dineli; Kufer, Peter; Hoffmann, Patrick; Raum, Tobias; Lutterbüse, Ralf; Nahrwold, Elisabeth; Blumel, Claudia, Antibody constructs for CDH19 and CD3.
  11. Zou Hua ; Henzel William J. ; Wang Xiaodong, Apaf-1 an activator of caspase-3.
  12. Ashkenazi Avi J., Apo-2 ligand.
  13. Ashkenazi Avi J. ; Chuntharapai Anan ; Kim Kyung Jin, Apo-2 ligand.
  14. Ashkenazi, Avi J., Apo-2 ligand.
  15. Ashkenazi,Avi J., Apo-2 ligand.
  16. Ashkenazi,Avi J., Apo-2 ligand.
  17. Adams, Camellia W.; Ashkenazi, Avi J.; Chuntharapai, Anan; Kim, Kyung Jin, Apo-2 receptor agonist antibodies.
  18. Ashkenazi, Avi J., Apo-2 receptor polynucleotides.
  19. Ashkenazi, Avi J., Apo-2 receptor polypeptides.
  20. Avi J. Ashkenazi, Apo-2-receptor.
  21. Avi J. Ashkenazi, Apo-2LI and Apo-3 polypeptides.
  22. Avi J. Ashkenazi, Apo-3 polypeptide.
  23. Kohno, Tadahiko, Apo-AI/AII peptide derivatives.
  24. Fischer, Saloumeh; Baker, Dana L.; Lowman, Henry B.; Nakamura, Gerald R., Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis.
  25. Evarts, Jerry B.; Ulrich, Roger G., Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use.
  26. Saxinger Carl, Automated Peptide design and synthesis.
  27. Fong Dodd W. (Naperville IL), Carboxylate containing modified acrylamide polymers.
  28. Fong Dodd W. (Naperville IL), Carboxylate containing modified acrylamide polymers.
  29. Walsh, Bradley; Campbell, Douglas; Justiniano Fuenmayor, Irene; Nocon, Aline; Soon, Julie; Truong, Quach; Wissmueller, Sandra; Russell, Pamela, Cell surface prostate cancer antigen for diagnosis.
  30. Lee Siu-Leung (Upper Arlington OH), Chromatographic process.
  31. Baciu, Peter C.; Liang, Yanbin; Guu, Jason; Bernett, Matthew; Muchhal, Umesh; Desjarlais, John, Complement component C5 antibodies.
  32. Gunawan, Feny; Hsiao, Yi-Chun; Krawitz, Denise C.; Lin, Margaret S.; Vanderlaan, Martin; Vij, Rajesh; Yuk, Inn H.; Zhu-Shimoni, Judith, Compositions and methods for detecting and quantifying host cells protein in cell lines and recombinant polypeptide products.
  33. Walker, Kenneth W.; Gegg, Jr., Colin V., Compositions and methods for producing bioactive fusion proteins.
  34. Hubbell Jeffrey A. ; Sawhney Amarpreet S., Compositions for coating microcapsules and other surfaces.
  35. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Khare, Taruna Arora; Adler, Beverly S.; Martin, Francis H., Conjugated toxin peptide therapeutic agents.
  36. Yang, Jihong; Quarmby, Valerie Elizabeth, Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule.
  37. Clogston, Christi L., Crystalline polypeptides.
  38. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V., DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression.
  39. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Arora Khare, Taruna; Adler, Beverly S.; Martin, Francis H., DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression.
  40. Pelletier, Jerry; Gros, Philippe; DuBow, Michael, DNA sequences from staphylococus aureus bacteriophages 3A, 77, and 96 that encode anti-microbial polypeptides.
  41. Pelletier,Jerry; Gros,Philippe; DuBow,Michael, DNA sequences frombacteriophage 77 that encode anti-microbial polypeptides.
  42. Pelletier, Jerry; Gros, Philippe; DuBow, Michael, Development of novel anti-microbial agents based on bacteriophage genomics.
  43. Fei, David Tai Wai; Tomita, Kristen, ELISA for VEGF.
  44. Fei, David Tai Wai; Tomita, Kristen, ELISA for VEGF.
  45. Srinivasan Vadake R. (Baton Rouge LA), Fungicidally active cellulosic textile compositions, or articles of manufacture.
  46. Marshall, William S.; Stark, Kevin Lee, Glucagon antagonists.
  47. Alitalo, Kari; Jeltsch, Markku Michael, Growth factor binding constructs materials and methods.
  48. Chen, Chih-Ming; Chou, Joseph; Wong, David, HMG-CoA reductase inhibitor extended release formulation.
  49. Carr Peter W. (Minneapolis MN) Funkenbusch Eric F. (White Bear Lake MN) Rigney Martin P. (Roseville MN) Coleman Patrick L. (Minneapolis MN) Hanggi Douglas A. (St. Paul MN) Schafer Wes A. (Minneapolis, High stability porous zirconium oxide spherules.
  50. Christenson, Erik; Demaggio, Anthony J.; Goldman, Phyllis S.; McElligott, David L., Human poly (ADP-ribose) polymerase 2 materials and methods.
  51. Christenson,Erik; DeMaggio,Anthony J.; Goldman,Phyllis S.; McElligott,David L., Human poly(ADP-ribose) polymerase 2 materials and methods.
  52. Hongo, Jo-Anne; Li, Yanhong; Liu, Luna; Lowe, John; Maia, Mauricio; Vij, Rajesh; Wong, Terence; Xu, Keyang, Idiotypic antibodies and uses thereof.
  53. Friedman Arthur (Churchville PA) Lehman E. Dale (Lansdale PA) McAleer William J. (Ambler PA) Schaefer Ted F. (Collegeville PA) Scolnick Edward M. (Wynnewood PA) Wampler D. Eugene (Harleysville PA), Immunogenic HbsAg derived from transformed yeast.
  54. Lazar, Gregory Alan; Dahiyat, Bassil I.; Dang, Wei; Karki, Sher Bahadur; Vafa, Omid, Immunoglobulin insertions, deletions, and substitutions.
  55. Lazar, Gregory; Dahiyat, Bassil; Dang, Wei; Karki, Sher Bahadur; Vafa, Omid, Immunoglobulins insertions, deletions, and substitutions.
  56. Adams,Camellia W.; Ashkenazi,Avi J.; Chuntharapai,Anan; Kim,Kyung Jin, Inducing apoptosis using anti-Apo-2 antibodies.
  57. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  58. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  59. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  60. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  61. Sadhu, Chanchal; Dick, Ken; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  62. Sadhu, Chanchal; Dick, Kenneth O.; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  63. Sadhu, Chanchal; Dick, Kennith O.; Treiberg, Jennifer; Sowell, C. Gregory; Kesicki, Edward A.; Oliver, Amy, Inhibitors of human phosphatidylinositol 3-kinase delta.
  64. Nyati, Mukesh K.; Lawrence, Theodore S., Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction.
  65. Richards, William L.; Ashby, Austin; Ketterer, Matthew; Marshall, Kevin; Harrison, Josh; Mette, Matthew; Richards, Paul; Showalter, Wayne; Cote, Jasmin; Halbert, Phillip C.; Bourgeois, Solene; Metzger, Steven W.; Hance, Ken; Mensack, Meghan; Michel, Carlos; Allers, Elke; Gamage, Dulini; Prisbrey, Landon; Gusyatin, Oleg; Shamsheyeva, Alena; Turng, Ben; Ghusson, Andrew; Reinhardt, Kurt, Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing.
  66. Richards, William L.; Ashby, Austin; Ketterer, Matthew; Marshall, Kevin; Harrison, Josh; Mette, Matthew; Richards, Paul; Showalter, Wayne; Cote, Jasmin; Halbert, Phillip C.; Bourgeois, Solene; Metzger, Steven W.; Hance, Ken; Mensack, Meghan; Michel, Carlos; Allers, Elke; Gamage, Dulini; Prisbrey, Landon; Gusyatin, Oleg; Shamsheyeva, Alena; Turng, Ben; Ghusson, Andrew; Reinhardt, Kurt, Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing.
  67. Blair, Henry; Beck, Thomas; Ladner, Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  68. Blair, Henry; Beck, Thomas; Ladner, Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  69. Blair, Henry; Beck, Thomas; Ladner, Robert Charles, Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  70. Blair,Henry; Beck,Thomas; Ladner,Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  71. Markland William ; Ladner Robert Charles, Kallikrein-binding "Kunitz domain" proteins and analogues thereof.
  72. Markland William ; Ladner Robert Charles, Kallikrein-binding "Kunitz domain" proteins and analogues thereof.
  73. Markland, William; Ladner, Robert C., Kallikrein-binding "Kunitz domain" proteins and analogues thereof.
  74. Markland, William; Ladner, Robert C., Kallikrein-binding “Kunitz domain” proteins and analogues thereof.
  75. Markland, William; Ladner, Robert C., Kallikrein-binding “kunitz domain” proteins and analogues thereof.
  76. Markland Willaim ; Ladner Robert Charles, Kallikrein-inhibiting "Kunitz Domain" proteins and analogues thereof.
  77. Markland Willaim ; Ladner Robert Charles, Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof.
  78. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Kallikrein-inhibitor therapies.
  79. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony; Grazia De Simoni, Maria; Bergamaschini, Luigi, Kallikrein-inhibitor therapies.
  80. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony; Simoni, Maria Grazia; Bergamaschini, Luigi, Kallikrein-inhibitor therapies.
  81. Ladner,Robert C.; Ley,Arthur C.; Hirani,Shirish; Williams,Anthony; De Simoni,Maria Grazia; Bergamaschini,Luigi, Kallikrein-inhibitor therapies.
  82. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  83. Callahan, William J.; Remmele, Jr., Richard L.; Ratnaswamy, Gayathri; Latypov, Ramil F.; Liu, Dingjiang, Lyophilized therapeutic peptibody formulations.
  84. Thomas Ciossek DE; Axel Ullrich ; Birgit Millauer, MDK1 polypeptides.
  85. Ciossek Thomas,DEX ; Ullrich Axel ; Millauer Birgit, MDKI, a novel receptor tyrosine kinase.
  86. Prisbrey, Landon; Blackmore, Elise; Hance, Kenneth R.; Metzger, Steven W.; Marshall, Kevin, Membrane-assisted purification.
  87. Coull James M. (Acton MA) Rappin Darryl J. (North Billerica MA) Koester Hubert (Concord MA) Pluskal Malcolm G. (Bedford MA) Steuck Michael J. (North Reading MA) Bonner Alex G. (Lexington MA), Membranes for solid phase protein sequencing.
  88. James Hoch ; Veronique Dartois, Metabolic selection methods.
  89. Gold, Daniel P.; Shopes, Robert J., Method and composition for altering a B cell mediated pathology.
  90. Gold, Daniel P.; Shopes, Robert J., Method and composition for altering a B cell mediated pathology.
  91. Gold, Daniel P.; Shopes, Robert J., Method and composition for altering a B cell mediated pathology.
  92. Gold, Daniel P.; Shopes, Robert J., Method and composition for altering a B cell mediated pathology.
  93. Muller Egbert (Erzhausen DEX), Method and supports for gel permeation chromatography.
  94. Starzl Timothy W. ; Nunnery David W. ; Robinson MaryBeth ; Hanlin H. John, Method for specific substance and molecule detection.
  95. Matthews William ; Austin Timothy W., Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides.
  96. Kauvar Lawrence M. (San Francisco CA), Method of identity analyte-binding peptides.
  97. Fulton, Chandler; Lai, Elaine Y., Method of including apoptosis by reducing the level of thiamin.
  98. Fulton, Chandler; Lai, Elaine Y., Method of inducing apoptosis by reducing the level of thiamin.
  99. Cohen, Yossi; Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Wool, Assaf; Dahary, Dvir; Hecht, Iris; Rotman, Galit; Ayalon-Soffer, Michal, Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands.
  100. Sexton, Daniel J.; Viswanathan, Malini, Method of treating hereditary angioedema using plasma kallikrein binding antibodies.
  101. Yu, X. Christopher; Fisher, Susan C.; Sanchez, Ailen M.; Vanderlaan, Martin, Methods and compositions comprising purified recombinant polypeptides.
  102. Radcliffe, Gail E.; Lapen, Daniel C.; Festel, Charles A., Methods for collecting fluid samples having select concentrations of particles.
  103. Ciossek,Thomas; Ullrich,Axel; Millauer,Birgit, Methods for diagnosis and treatment of MDK1 signal transduction disorders.
  104. Cicardi, Marco; Bergamaschini, Luigi, Methods for preserving organs and tissues.
  105. Cicardi, Marco; Bergamaschini, Luigi, Methods for preserving organs and tissues.
  106. Cicardi,Marco; Bergamaschini,Luigi, Methods for preserving organs and tissues.
  107. Gold, Leslie I.; Michalak, Marek, Methods for treating diabetic wounds.
  108. Gold, Leslie I.; Michalak, Marek, Methods for treating diabetic wounds.
  109. Puri, Kamal D.; Evarts, Jerry B.; Lannutti, Brian; Giese, Neill, Methods of treatment for solid tumors.
  110. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., Methods of using OSK1 peptide analogs.
  111. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  112. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  113. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  114. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  115. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  116. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  117. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  118. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  119. Gegg, Colin; Xiong, Fei; Sitney, Karen C., Modified Fc molecules.
  120. Gegg,Colin; Xiong,Fei; Sitney,Karen C., Modified Fc molecules.
  121. Boos Karl Siegfried,DEX ; Walfort Andreas,DEX ; Eisenbeiss Friedhelm,DEX ; Lubda Dieter,DEX, Modified chromatographic support materials.
  122. Feige,Ulrich, Modified peptides as therapeutic agents.
  123. Baciu, Peter C.; Liang, Yanbin; Guu, Jason; Bernett, Matthew; Muchhal, Umesh; Desjarlais, John, Nucleic acids encoding complement component C5 antibodies.
  124. Keyt Bruce A. ; Nguyen Francis Hung ; Ferrara Napoleone, Nucleic acids encoding variants of vascular endothelial cell growth factor.
  125. Wang Yang ; Spellman Michael W., O-fucosyltransferase.
  126. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., OSK1 peptide analogs and pharmaceutical compositions.
  127. Blaschke Gottfried (Mnster DEX) Fraenkel Werner (Bad Rothenfelde DEX) Brker Werner (Mnster DEX) Kinkel Joachim (Guidental DEX), Optically active adsorbents.
  128. Barbosa, Maria D.; Chamberlain, Aaron K.; Desjarlais, John R., Optimized proteins that target Ep-CAM.
  129. Schlessinger, Joseph; Okigaki, Mitsuhiko; Gishizky, Mikhail, PYK2 and inflammation.
  130. Schlessinger Joseph ; Lev Sima, PYK2 related polynucleotide products.
  131. Oi Naobumi (Kyoto JPX) Kitahara Hajimu (Osaka JPX) Doi Tadashi (Osaka JPX), Packing material for chromatographic use.
  132. Chemtob,Sylvain; Peri,Krishna G., Peptide antagonists of prostaglandin F2α receptor.
  133. Cohen, Yossi; Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Wool, Assaf; Dahary, Dvir; Hecht, Iris; Beiman, Merav; Rotman, Galit; Ayalon-Soffer, Michal, Peptide ligands for G-protein coupled receptors.
  134. Peri, Krishna; Polyak, Felix; Lubell, William; Thouin, Eryk; Chemtob, Sylvain, Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor.
  135. Peri, Krishna; Polyak, Felix; Lubell, William; Thouin, Eryk; Chemtob, Sylvain, Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin Freceptor.
  136. Min,Hosung; Sitney,Karen C.; Hartley,Cynthia, Peptides and related compounds having thrombopoietic activity.
  137. Cohen, Yossi; Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Wool, Assaf; Dahary, Dvir; Hecht, Iris; Rotman, Galit; Ayalon-Soffer, Michal, Peptides which bind to G protein-coupled receptors.
  138. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  139. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  140. Jiang, Dayue D., Poly(amino-alcohol)-silica hybrid compositions and membranes.
  141. Lambert Nada,FRX ; Labarre Denis,FRX ; Fessi Hatem,FRX, Polycarboxylic based cross-linked copolymers.
  142. Funkenbusch Eric F. (St. Paul MN) Carr Peter W. (Minneapolis MN) Hanggi Douglas A. (St. Paul MN) Weber Thomas P. (St. Paul MN), Polymer-coated carbon-clad inorganic oxide particles.
  143. Carra, Ernest; Gerber, Michael; Shi, Bing; Sujino, Keiko; Tran, Duong; Wang, Fang; Evarts, Jerry B., Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one.
  144. Carra, Ernest; Gerber, Michael; Shi, Bing; Sujino, Keiko; Tran, Duong; Wang, Fang; Evarts, Jerry B., Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one.
  145. Buttar, Suzanne; Carra, Ernest; Ehiwe, Tracy; Tran, Duong; Wang, Fang; Worrall, Christopher; Evarts, Jerry, Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one.
  146. Ladner, Robert C.; Ley, Arthur C., Prevention and reduction of blood loss.
  147. Ladner, Robert C.; Ley, Arthur C., Prevention and reduction of blood loss.
  148. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  149. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  150. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  151. Ladner, Robert Charles; Ley, Arthur Charles; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  152. Ladner,Robert C.; Ley,Arthur C.; Hirani,Shirish; Williams,Anthony, Prevention and reduction of blood loss.
  153. Ladner,Robert C.; Ley,Arthur C.; Hirani,Shirish; Williams,Anthony, Prevention and reduction of blood loss.
  154. Bremner, Stacy; Evarts, Jerry; Sujino, Keiko; Tran, Duong; Vizitiu, Dragos, Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof.
  155. Hammen Richard Frederick, Process for separating a substance from a mixture.
  156. Bremner, Stacy; Evarts, Jerry; Sujino, Keiko; Tran, Duong; Vizitiu, Dragos, Process methods for phosphatidylinositol 3-kinase inhibitors.
  157. Bremner, Stacy; Evarts, Jerry; Sujino, Keiko; Tran, Duong; Vizitiu, Dragos, Process methods for phosphatidylinositol 3-kinase inhibitors.
  158. Hsia Jen-chang (Concord CAX), Purification of hemoglobin and modified hemoglobin by affinity chromatography.
  159. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer, Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta.
  160. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta.
  161. Fowler, Kerry W.; Huang, Danwen; Kesicki, Edward A.; Ooi, Hua Chee; Oliver, Amy; Ruan, Fuqiang; Treiberg, Jennifer; Puri, Kamal Deep, Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta.
  162. Metzger, Steven W.; Hance, Kenneth Robert, Rapid cell purification systems.
  163. Metzger, Steven W.; Hance, Kenneth Robert, Rapid cell purification systems.
  164. Metzger, Steven W.; Hance, Kenneth Robert, Rapid cell purification systems.
  165. Shamsheyeva, Alena; Howson, David C.; Metzger, Steven W., Rapid determination of microbial growth and antimicrobial susceptibility.
  166. Metzger, Steven W.; Howson, David C.; Goldberg, David A.; Buttry, Daniel A., Rapid microbial detection and antimicrobial susceptibility testing.
  167. Yuki Yoichi (Himeji JPX) Okamoto Ichiro (Himeji JPX) Shibata Tohru (Himeji JPX) Nakamura Hiroyuki (Himeji JPX), Resolving agent.
  168. Yuki Yoichi (Himeji JPX) Okamoto Ichiro (Himeji JPX) Shibata Tohru (Himeji JPX) Nakamura Hiroyuki (Himeji JPX), Resolving agent.
  169. Starzl Timothy W. ; Nunnery David W. ; Robinson MaryBeth ; Hanlin H. John, Sensing system for specific substance and molecule detection.
  170. Goldberg, David A.; Howson, David C.; Metzger, Steven W.; Buttry, Daniel A.; Saavedra, Steven Scott, Sensitive and rapid determination of antimicrobial susceptibility.
  171. Goldberg, David A.; Howson, David C.; Metzger, Steven W.; Buttry, Daniel A.; Saavedra, Steven Scott, Sensitive and rapid determination of antimicrobial susceptibility.
  172. Okamoto Yoshio (Amagasaki JPX) Hatada Koichi (Ikeda JPX) Shibata Tohru (Himeji JPX) Okamoto Ichiro (Himeji JPX) Nakamura Hiroyuki (Himeji JPX), Separating agent.
  173. Okamoto, Yoshio; Hatada, Koichi; Shibata, Tohru; Okamoto, Ichiro; Nakamura, Hiroyuki, Separating agent.
  174. Namikoshi Hajime (Himeji JPX) Shibata Tohru (Himeji JPX) Okamoto Ichiro (Himeji JPX), Separation agent comprising acyl- or carbamoyl-substituted polysaccharide.
  175. Namikoshi Hajime (Himeji JPX) Shibata Tohru (Himeji JPX) Okamoto Ichiro (Himeji JPX), Separation agent comprising acyl- or carbamoyl-substituted polysaccharide.
  176. Namikoshi Hajime (Himeji JPX) Shibata Tohru (Himeji JPX) Okamoto Ichiro (Himeji JPX), Separation agent comprising acyl- or carbamoyl-substituted polysaccharide.
  177. Rendleman ; Jr. Jacob A. (Metamora IL), Separation of cyclodextrins by affinity chromatography.
  178. Bert O'Malley ; Ming-Jer Tsai ; Sophia Y. Tsai ; Sergio Onate, Steroid receptor coactivator compositions and methods of use.
  179. Ashkenazi, Avi J.; Kelley, Robert F.; O'Connell, Mark P.; Pitti, Robert M.; Schwall, Ralph A., Substitutional variants of APO-2 ligand.
  180. Gold, Leslie I.; Michalak, Marek, Therapeutic and cosmetic uses and applications of calreticulin.
  181. Walker, Kenneth W.; Kinstler, Olaf B.; Sitney, Karen C., Therapeutic peptides.
  182. Gallatin, W. Michael; Ulrich, Roger G.; Giese, Neill A., Therapies for hematologic malignancies.
  183. Gallatin, W. Michael; Ulrich, Roger G.; Giese, Neill A.; Lannutti, Brian; Miller, Langdon; Jahn, Thomas M., Therapies for hematologic malignancies.
  184. Gallatin, W. Michael; Ulrich, Roger G.; Giese, Neill A.; Lannutti, Brian; Miller, Langdon; Jahn, Thomas M., Therapies for hematologic malignancies.
  185. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  186. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  187. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  188. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  189. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  190. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  191. Liu, Chuan-Fa; Feige, Ulrich; Cheetham, Janet C., Thrombopoietic compounds.
  192. Min, Hosung; Walker, Kenneth W.; Gegg, Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  193. Min, Hosung; Walker, Kenneth W.; Gegg, Jr., Colin V.; Galimi, Francesco; Sun, Jeonghoon; Tsai, Mei-Mei, Thrombopoietic compounds.
  194. Adams, Camellia W.; Ashkenazi, Avi J.; Chuntharapai, Anan; Kim, Kyung Jin, Treatment of cancer using anti-Apo-2 antibodies.
  195. Ulrich, Roger G., Treatment of liver disorders with PI3K inhibitors.
  196. Sternlicht, Andrew, Treatment of mucositis with kallikrein inhibitors.
  197. Margolis Ben Lewis ; Schlessinger Joseph, Treatment or diagnosis of diseases or conditions associated with a BLM domain.
  198. Wong, Marc; Yee, Liliana T.; Lim, Amy; Fong, Chris B., Ultrapurified DsbA and DsbC and methods of making and using the same.
  199. Orlovsky,Vladislav; Zelechonok,Yury, Universal bonded phase material for chromatographic separation.
  200. Matthews William ; Austin Timothy W., Uses of Wnt polypeptides.
  201. Alitalo,Kari; Jeltsch,Markku M., VEGFR-3 fusion proteins.
  202. Keyt Bruce A. ; Nguyen Francis Hung ; Ferrara Napoleone ; Cunningham Brian C. ; Wells James A. ; Li Bing, Variants of vascular endothelial cell growth factor.
  203. Keyt,Bruce A.; Nguyen,Francis Hung; Ferrara,Napoleone, Variants of vascular endothelial cell growth factor.
  204. Keyt,Bruce A.; Nguyen,Francis Hung; Ferrara,Napoleone, Variants of vascular endothelial cell growth factor, their uses, and processes for their production.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로